Abstract
Background: Behavior difficulties such as irritability, aggression, and repetitive and challenging behaviors are common in children with Autism Spectrum Disorder (ASD) and other developmental disabilities (DD). Atypical antipsychotic medications (AAPM) are currently first-line pharmacological agents for treatment of these behaviors. However, there are significant associated adverse effects of AAPM in children, including excessive weight gain, abnormal involuntary movements, and laboratory abnormalities. A recent chart review of children with ASD treated with AAPM revealed that 40% had overweight or obesity (OW/OB). Problem: Despite significant long-term health risks, the Division of Developmental and …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have